커넥티드 헬스 및 웰니스 솔루션 : 시장 점유율 분석, 업계 동향 및 통계, 성장 예측(2026-2031년)

According to Mordor Intelligence, the connected health and wellness solutions market is projected to expand from USD 78.75 billion in 2025, USD 94.24 billion in 2026, and reach USD 244.74 billion by 2031, growing at a CAGR of 21.03% from 2026 to 2031.

This report is Segmented by Product Type (Personal Medical Devices, Wellness Products, Software and Services), Function (Remote Patient Monitoring, and Others), Application (Diagnosis and Treatment, and Others), End-User (Hospitals and Clinics, and Others), and Geography (North America, Europe, Asia-Pacific, and Others). The Market Forecasts are Provided in Terms of Value (USD).

Global Connected Health and Wellness Solutions Market Trends and Insights

Increasing Chronic Disease Monitoring Demand

The connected health and wellness solutions market is being shaped by a disease burden that is persistent across both mature and developing healthcare systems. Noncommunicable diseases accounted for 74% of global annual mortality, and the WHO reported in 2025 that most countries were still off track on their reduction commitments. In the United States, CDC data published in 2025 showed that 74% of adults reported at least 1 chronic condition in 2023, while 51% reported multiple conditions, which reinforces demand for long-duration monitoring tools across the connected health and wellness solutions market.A 2026 systematic review in JMIR also pointed back to the CDC finding that chronic disease spending consumes 90% of U.S. healthcare expenditure, which means the cost case for prevention and monitoring remains intact. This keeps demand in the connected health and wellness solutions market tied to a structural healthcare need rather than a short-cycle technology purchase, which supports more predictable revenue planning for platform operators.

Shift from Episodic Care to Continuous Wellness Management

The connected health and wellness solutions market is moving with a broader care model shift from reactive visits toward continuous patient management. Traditional visits only capture a short point in time, while connected devices can generate longitudinal data that helps teams identify deterioration earlier and follow patients between encounters. The FDA's TEMPO pilot, launched in January 2026, shows that regulators now recognize the importance of digital tools that can demonstrate meaningful patient outcomes in routine care. That policy signal favors the connected health and wellness market segments that already combine monitoring, virtual touchpoints, and evidence generation inside a single workflow. It also means that vendors collecting deeper longitudinal datasets can build a stronger position for future regulatory submissions and payer discussions than vendors that only provide isolated device readings.

Data Privacy, Cybersecurity, and Consent Friction

The connected health and wellness solutions market depends on continuous flows of biometric and behavioral data, and that makes trust a core adoption requirement. As more devices collect data outside hospitals and clinics, vendors must manage consent, identity, storage, and sharing expectations across multiple care settings. This slows deployment because providers do not only evaluate clinical performance, they also examine how a platform handles connected sensor data through the full care process. The same issue affects patients because long term adoption is harder when data use terms are unclear or when monitoring feels more intrusive than supportive. In the connected health and wellness solutions market, weak security design can therefore delay contracts, reduce utilization, and increase pressure on vendors to prove end to end governance before scale deployment.

Other drivers and restraints analyzed in the detailed report include:

1. Consumer Adoption of Wearables and Health Apps
2. Edge AI and Sensor Miniaturization Improve Clinical Utility
3. Uneven Reimbursement and Device Validation Across Markets

For complete list of drivers and restraints, kindly check the Table Of Contents.

Segment Analysis

Personal medical devices held 52.46% of connected health and wellness solutions market share in 2025, which kept this category in the lead because clinically validated hardware still moves through reimbursement backed procurement channels with more predictable pricing. This part of the connected health and wellness solutions market includes continuous glucose monitors, ambulatory cardiac monitors, and remote vital sign patches that already fit into established care pathways.

Wellness products are forecasted to grow at a 23.85% CAGR, and the connected health and wellness solutions market size for this segment is rising as sensor costs fall and access widens beyond tightly defined clinical use cases. Software and services still represent a smaller revenue base, but this is where the connected health and wellness solutions industry is building stronger moats as hardware becomes easier to compare across vendors. Providers and payers are placing more value on analytics, decision support, and integration features because those layers shape long term stickiness after the device sale.

Remote patient monitoring held 48.92% share in 2025, which reflects its established role in discharge protocols, chronic care management, and value-based programs that encourage care at home. The connected health and wellness solutions market has given RPM a strong commercial base because cardiology, pulmonology, and diabetes already have years of clinical validation behind continuous monitoring models. This makes RPM easier for providers to justify in budget cycles because the link to readmission reduction and follow-up adherence is clearer than in newer digital categories. It also keeps RPM closely tied to the parts of healthcare where cost avoidance can be measured more directly.

Telehealth is projected to expand at a 24.71% CAGR, and the connected health and wellness solutions market size tied to virtual care functions should keep rising as billing rules become easier to navigate. Clinical monitoring remains important in institutional settings, but alarm fatigue documented in ICU settings increases the need for better prioritization and signal filtering rather than more alerts alone.

Complete Report Scope:

• By Product Type
  • Personal Medical Devices
  • Wellness Products
  • Software and Services
• By Function
  • Remote Patient Monitoring
  • Clinical Monitoring
  • Telehealth
• By Application
  • Diagnosis and Treatment
  • Monitoring Applications
  • Wellness and Prevention
  • Healthcare Management
• By End-User
  • Hospitals and Clinics
  • Homecare Settings
  • Ambulatory and Specialty Clinics
  • Other End-Users
• By Geography
  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • Germany
    • United Kingdom
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • Middle East and Africa
    • GCC
    • South Africa
    • Rest of Middle East and Africa
  • South America
    • Brazil
    • Argentina
    • Rest of South America

Geography Analysis

North America held 42.84% of connected health and wellness solutions market share in 2025, which kept the region in front because it combines a high concentration of FDA cleared devices with a more mature telehealth reimbursement base and a faster moving interoperability agenda. The Office of the National Coordinator's Draft USCDI Version 7, released in January 2026, advances data standardization for wearable and device generated health data, and that will continue shaping platform design choices in the connected health and wellness solutions market. The United States remains the regional anchor because regulatory clarity, payer alignment, and enterprise health IT spending are all stronger than in most other markets.

The connected health and wellness solutions market in Europe is moving on a different path, with reimbursement design and cross border data governance playing a larger role in adoption. Germany's DiGA framework remains one of the clearest prescription digital health reimbursement models for software led care in the region. The United Kingdom is continuing to use remote patient monitoring more actively in post acute cardiovascular and respiratory pathways as workforce pressure pushes care outside traditional settings. France, Italy, and Spain are still following rather than leading these platform adoption patterns, and investment remains linked to national health IT budget cycles. Across the region, the European Health Data Space and the EU Medical Device Regulation should gradually reduce fragmentation and support wider deployment, while recent device approvals.

Asia-Pacific is forecasted to grow at a 27.46% CAGR, and the connected health and wellness solutions market size in the region is being lifted by strong demographic demand, public digital health investment, and a deep consumer electronics manufacturing base. Government backed infrastructure and broader familiarity with mobile first services create a favorable environment for remote monitoring and virtual care expansion across the connected health and wellness solutions market. The Middle East and Africa and South America remain earlier stage, but GCC countries and Brazil stand out for near term potential even as legacy health IT systems continue to raise integration costs and slow rollout speed.

1. Abbott Laboratories
2. Alphabet Inc.
3. Amazon.com
4. Apple
5. Boston Scientific
6. Dexcom
7. Garmin
8. GE Healthcare
9. Hinge Health, Inc.
10. iRhythm Technologies
11. Koninklijke Philips
12. Masimo
13. Medtronic
14. Omada Health
15. OMRON
16. Resmed
17. Samsung Group
18. Siemens Healthineers
19. Teladoc Health
20. Withings SA

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support

TABLE OF CONTENTS

1 Introduction

• 1.1 Study Assumptions and Market Definition
• 1.2 Scope of the Study

2 Research Methodology

3 Executive Summary

4 Market Landscape

• 4.1 Market Overview
• 4.2 Market Drivers
  • 4.2.1 Increasing Chronic Disease Monitoring Demand
  • 4.2.2 Expansion of Remote Patient Monitoring Reimbursement
  • 4.2.3 Shift from Episodic Care to Continuous Wellness Management
  • 4.2.4 Consumer Adoption of Wearables and Health Apps
  • 4.2.5 Edge AI and Sensor Miniaturization Improve Clinical Utility
  • 4.2.6 Interoperable Telehealth and Consumer Tech Ecosystems
• 4.3 Market Restraints
  • 4.3.1 Workflow Integration Complexity Across Clinical Departments
  • 4.3.2 Data Privacy, Security, and AI Governance Burden
  • 4.3.3 Interoperability Gaps Across Legacy EHR and Practice Management Systems
  • 4.3.4 Change Management Friction and Staff Adoption Lag
• 4.4 Value Chain Analysis
• 4.5 Regulatory Landscape
• 4.6 Technological Outlook
• 4.7 Porter's Five Forces Analysis
  • 4.7.1 Threat of New Entrants
  • 4.7.2 Bargaining Power of Suppliers
  • 4.7.3 Bargaining Power of Buyers
  • 4.7.4 Threat of Substitutes
  • 4.7.5 Competitive Rivalry

5 Market Size & Growth Forecasts (Value, USD)

• 5.1 By Product Type
  • 5.1.1 Personal Medical Devices
  • 5.1.2 Wellness Products
  • 5.1.3 Software and Services
• 5.2 By Function
  • 5.2.1 Remote Patient Monitoring
  • 5.2.2 Clinical Monitoring
  • 5.2.3 Telehealth
• 5.3 By Application
  • 5.3.1 Diagnosis and Treatment
  • 5.3.2 Monitoring Applications
  • 5.3.3 Wellness and Prevention
  • 5.3.4 Healthcare Management
• 5.4 By End-User
  • 5.4.1 Hospitals and Clinics
  • 5.4.2 Homecare Settings
  • 5.4.3 Ambulatory and Specialty Clinics
  • 5.4.4 Other End-Users
• 5.5 By Geography
  • 5.5.1 North America
    • 5.5.1.1 United States
    • 5.5.1.2 Canada
    • 5.5.1.3 Mexico
  • 5.5.2 Europe
    • 5.5.2.1 Germany
    • 5.5.2.2 United Kingdom
    • 5.5.2.3 France
    • 5.5.2.4 Italy
    • 5.5.2.5 Spain
    • 5.5.2.6 Rest of Europe
  • 5.5.3 Asia-Pacific
    • 5.5.3.1 China
    • 5.5.3.2 Japan
    • 5.5.3.3 India
    • 5.5.3.4 Australia
    • 5.5.3.5 South Korea
    • 5.5.3.6 Rest of Asia-Pacific
  • 5.5.4 Middle East and Africa
    • 5.5.4.1 GCC
    • 5.5.4.2 South Africa
    • 5.5.4.3 Rest of Middle East and Africa
  • 5.5.5 South America
    • 5.5.5.1 Brazil
    • 5.5.5.2 Argentina
    • 5.5.5.3 Rest of South America

6 Competitive Landscape

• 6.1 Market Concentration
• 6.2 Market Share Analysis
• 6.3 Company Profiles (includes Global level Overview, Market level overview, Core Segments, Financials as available, Strategic Information, Market Rank/Share for key companies, Products & Services, Recent Developments)
  • 6.3.1 Abbott Laboratories
  • 6.3.2 Alphabet Inc.
  • 6.3.3 Amazon.com, Inc.
  • 6.3.4 Apple Inc.
  • 6.3.5 Boston Scientific Corporation
  • 6.3.6 Dexcom, Inc.
  • 6.3.7 Garmin Ltd.
  • 6.3.8 GE HealthCare
  • 6.3.9 Hinge Health, Inc.
  • 6.3.10 iRhythm Technologies, Inc.
  • 6.3.11 Koninklijke Philips N.V.
  • 6.3.12 Masimo Corporation
  • 6.3.13 Medtronic plc
  • 6.3.14 Omada Health, Inc.
  • 6.3.15 OMRON Corporation
  • 6.3.16 ResMed Inc.
  • 6.3.17 Samsung Electronics Co., Ltd.
  • 6.3.18 Siemens Healthineers AG
  • 6.3.19 Teladoc Health, Inc.
  • 6.3.20 Withings SA

7 Market Opportunities & Future Outlook

• 7.1 White-space & Unmet-need Assessment